Skip to main content
. 2019 Nov 30;95(1):57–62. doi: 10.1016/j.abd.2019.06.004

Table 3.

Treatment of patients with cutaneous sarcoidosis.

Characteristics Patient number Percentage (%)
Only local therapy 12 17
 Topical glucocorticoid 10 83
 Intralesional glucocorticoid 5 42
 Topical calcineurin inhibitor 3 25
Systemic therapy 52 72
 Oral glucocorticoid 48 92
 Antimalarial 28 54
 Methotrexate 18 35
 Azathioprine 4 8
 Leflunomide 2 4
 Tetracycline-class antibiotics 2 4
 Thalidomide 1 2
 Infliximab 1 2